img

Global Next-Generation Oncology Solution Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Next-Generation Oncology Solution Market Insights, Forecast to 2034

Next-generation oncology solutions refer to the advanced and innovative technologies, treatments, and approaches used to diagnose, treat, and manage cancer more effectively and efficiently. These solutions aim to improve patient outcomes, enhance precision medicine, and streamline oncology care by leveraging cutting-edge technologies and personalized treatment approaches.
Market Analysis and InsightsGlobal Next-Generation Oncology Solution Market
Global Next-Generation Oncology Solution market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Next-Generation Oncology Solution industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for next-generation oncology solutions has been witnessing substantial growth and innovation, driven by advancements in genomics, precision medicine, immunotherapy, and data analytics. These cutting-edge solutions are transforming cancer care by providing more personalized and effective treatment options for patients. The rising incidence of cancer worldwide is propelling the demand for advanced oncology solutions that can offer better treatment outcomes and improved patient care. Precision medicine approaches, which use genomic testing and targeted therapies, have gained prominence, driving the adoption of next-gen oncology solutions. The United States, in particular, is a major market for next-gen oncology solutions due to its robust research and development infrastructure, extensive clinical trials, and high cancer incidence. European countries have been early adopters of precision medicine and advanced oncology treatments, contributing to the growth of the market in this region. The Asia-Pacific region is witnessing significant growth in the oncology market, with countries like China, India, and Japan investing in healthcare infrastructure and research. The global market for next-generation oncology solutions is expected to continue its growth trajectory in the coming years. As technology continues to advance, precision medicine becomes more personalized, and immunotherapy gains further momentum, next-gen oncology solutions are likely to play an increasingly significant role in cancer care. Moreover, collaborations between pharmaceutical companies, research institutions, and healthcare providers are likely to drive innovation and accelerate the development and adoption of next-gen oncology treatments worldwide.
Report Covers
This report presents an overview of global Next-Generation Oncology Solution market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Next-Generation Oncology Solution market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Paige
GE Healthcare
Varian
Brainlab
Qiagen
Hologic
Pacific Biosciences
AstraZeneca
BGI Group
Segment by Type
Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Software
Others

Segment by Application


Hospitals
Diagnostic Imaging Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Next-Generation Oncology Solution introduction, etc. Next-Generation Oncology Solution Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Next-Generation Oncology Solution
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Oncology Solution Market Perspective (2018-2033)
2.2 Global Next-Generation Oncology Solution Growth Trends by Region
2.2.1 Next-Generation Oncology Solution Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next-Generation Oncology Solution Historic Market Size by Region (2018-2023)
2.2.3 Next-Generation Oncology Solution Forecasted Market Size by Region (2024-2033)
2.3 Next-Generation Oncology Solution Market Dynamics
2.3.1 Next-Generation Oncology Solution Industry Trends
2.3.2 Next-Generation Oncology Solution Market Drivers
2.3.3 Next-Generation Oncology Solution Market Challenges
2.3.4 Next-Generation Oncology Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Next-Generation Oncology Solution by Players
3.1.1 Global Next-Generation Oncology Solution Revenue by Players (2018-2023)
3.1.2 Global Next-Generation Oncology Solution Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Next-Generation Oncology Solution, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Next-Generation Oncology Solution Market Concentration Ratio
3.4.1 Global Next-Generation Oncology Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Oncology Solution Revenue in 2022
3.5 Global Key Players of Next-Generation Oncology Solution Head office and Area Served
3.6 Global Key Players of Next-Generation Oncology Solution, Product and Application
3.7 Global Key Players of Next-Generation Oncology Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Oncology Solution Breakdown Data by Type
4.1 Global Next-Generation Oncology Solution Historic Market Size by Type (2018-2023)
4.2 Global Next-Generation Oncology Solution Forecasted Market Size by Type (2024-2033)
5 Next-Generation Oncology Solution Breakdown Data by Application
5.1 Global Next-Generation Oncology Solution Historic Market Size by Application (2018-2023)
5.2 Global Next-Generation Oncology Solution Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next-Generation Oncology Solution Market Size (2018-2033)
6.2 North America Next-Generation Oncology Solution Market Size by Type
6.2.1 North America Next-Generation Oncology Solution Market Size by Type (2018-2023)
6.2.2 North America Next-Generation Oncology Solution Market Size by Type (2024-2033)
6.2.3 North America Next-Generation Oncology Solution Market Share by Type (2018-2033)
6.3 North America Next-Generation Oncology Solution Market Size by Application
6.3.1 North America Next-Generation Oncology Solution Market Size by Application (2018-2023)
6.3.2 North America Next-Generation Oncology Solution Market Size by Application (2024-2033)
6.3.3 North America Next-Generation Oncology Solution Market Share by Application (2018-2033)
6.4 North America Next-Generation Oncology Solution Market Size by Country
6.4.1 North America Next-Generation Oncology Solution Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Next-Generation Oncology Solution Market Size by Country (2018-2023)
6.4.3 North America Next-Generation Oncology Solution Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Next-Generation Oncology Solution Market Size (2018-2033)
7.2 Europe Next-Generation Oncology Solution Market Size by Type
7.2.1 Europe Next-Generation Oncology Solution Market Size by Type (2018-2023)
7.2.2 Europe Next-Generation Oncology Solution Market Size by Type (2024-2033)
7.2.3 Europe Next-Generation Oncology Solution Market Share by Type (2018-2033)
7.3 Europe Next-Generation Oncology Solution Market Size by Application
7.3.1 Europe Next-Generation Oncology Solution Market Size by Application (2018-2023)
7.3.2 Europe Next-Generation Oncology Solution Market Size by Application (2024-2033)
7.3.3 Europe Next-Generation Oncology Solution Market Share by Application (2018-2033)
7.4 Europe Next-Generation Oncology Solution Market Size by Country
7.4.1 Europe Next-Generation Oncology Solution Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Next-Generation Oncology Solution Market Size by Country (2018-2023)
7.4.3 Europe Next-Generation Oncology Solution Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Next-Generation Oncology Solution Market Size (2018-2033)
8.2 China Next-Generation Oncology Solution Market Size by Type
8.2.1 China Next-Generation Oncology Solution Market Size by Type (2018-2023)
8.2.2 China Next-Generation Oncology Solution Market Size by Type (2024-2033)
8.2.3 China Next-Generation Oncology Solution Market Share by Type (2018-2033)
8.3 China Next-Generation Oncology Solution Market Size by Application
8.3.1 China Next-Generation Oncology Solution Market Size by Application (2018-2023)
8.3.2 China Next-Generation Oncology Solution Market Size by Application (2024-2033)
8.3.3 China Next-Generation Oncology Solution Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Next-Generation Oncology Solution Market Size (2018-2033)
9.2 Asia Next-Generation Oncology Solution Market Size by Type
9.2.1 Asia Next-Generation Oncology Solution Market Size by Type (2018-2023)
9.2.2 Asia Next-Generation Oncology Solution Market Size by Type (2024-2033)
9.2.3 Asia Next-Generation Oncology Solution Market Share by Type (2018-2033)
9.3 Asia Next-Generation Oncology Solution Market Size by Application
9.3.1 Asia Next-Generation Oncology Solution Market Size by Application (2018-2023)
9.3.2 Asia Next-Generation Oncology Solution Market Size by Application (2024-2033)
9.3.3 Asia Next-Generation Oncology Solution Market Share by Application (2018-2033)
9.4 Asia Next-Generation Oncology Solution Market Size by Region
9.4.1 Asia Next-Generation Oncology Solution Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Next-Generation Oncology Solution Market Size by Region (2018-2023)
9.4.3 Asia Next-Generation Oncology Solution Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type
10.2.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application
10.3.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country
10.4.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next-Generation Oncology Solution Introduction
11.1.4 Illumina Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.1.5 Illumina Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Next-Generation Oncology Solution Introduction
11.2.4 PerkinElmer Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.2.5 PerkinElmer Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Introduction
11.3.4 Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Roche Holding
11.4.1 Roche Holding Company Details
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Next-Generation Oncology Solution Introduction
11.4.4 Roche Holding Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.4.5 Roche Holding Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Next-Generation Oncology Solution Introduction
11.5.4 Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.5.5 Agilent Technologies Recent Developments
11.6 Paige
11.6.1 Paige Company Details
11.6.2 Paige Business Overview
11.6.3 Paige Next-Generation Oncology Solution Introduction
11.6.4 Paige Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.6.5 Paige Recent Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Next-Generation Oncology Solution Introduction
11.7.4 GE Healthcare Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.7.5 GE Healthcare Recent Developments
11.8 Varian
11.8.1 Varian Company Details
11.8.2 Varian Business Overview
11.8.3 Varian Next-Generation Oncology Solution Introduction
11.8.4 Varian Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.8.5 Varian Recent Developments
11.9 Brainlab
11.9.1 Brainlab Company Details
11.9.2 Brainlab Business Overview
11.9.3 Brainlab Next-Generation Oncology Solution Introduction
11.9.4 Brainlab Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.9.5 Brainlab Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Next-Generation Oncology Solution Introduction
11.10.4 Qiagen Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.10.5 Qiagen Recent Developments
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Next-Generation Oncology Solution Introduction
11.11.4 Hologic Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.11.5 Hologic Recent Developments
11.12 Pacific Biosciences
11.12.1 Pacific Biosciences Company Details
11.12.2 Pacific Biosciences Business Overview
11.12.3 Pacific Biosciences Next-Generation Oncology Solution Introduction
11.12.4 Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.12.5 Pacific Biosciences Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Next-Generation Oncology Solution Introduction
11.13.4 AstraZeneca Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.13.5 AstraZeneca Recent Developments
11.14 BGI Group
11.14.1 BGI Group Company Details
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Next-Generation Oncology Solution Introduction
11.14.4 BGI Group Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.14.5 BGI Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next-Generation Oncology Solution Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Table 3. Key Players of Software
Table 4. Key Players of Others
Table 5. Global Next-Generation Oncology Solution Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Next-Generation Oncology Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Next-Generation Oncology Solution Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Next-Generation Oncology Solution Market Share by Region (2018-2023)
Table 9. Global Next-Generation Oncology Solution Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Next-Generation Oncology Solution Market Share by Region (2024-2033)
Table 11. Next-Generation Oncology Solution Market Trends
Table 12. Next-Generation Oncology Solution Market Drivers
Table 13. Next-Generation Oncology Solution Market Challenges
Table 14. Next-Generation Oncology Solution Market Restraints
Table 15. Global Next-Generation Oncology Solution Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Next-Generation Oncology Solution Revenue Share by Players (2018-2023)
Table 17. Global Top Next-Generation Oncology Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Oncology Solution as of 2022)
Table 18. Global Next-Generation Oncology Solution Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Next-Generation Oncology Solution Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Next-Generation Oncology Solution, Headquarters and Area Served
Table 21. Global Key Players of Next-Generation Oncology Solution, Product and Application
Table 22. Global Key Players of Next-Generation Oncology Solution, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Next-Generation Oncology Solution Revenue Market Share by Type (2018-2023)
Table 26. Global Next-Generation Oncology Solution Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Next-Generation Oncology Solution Revenue Market Share by Type (2024-2033)
Table 28. Global Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Next-Generation Oncology Solution Revenue Share by Application (2018-2023)
Table 30. Global Next-Generation Oncology Solution Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Next-Generation Oncology Solution Revenue Share by Application (2024-2033)
Table 32. North America Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Next-Generation Oncology Solution Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Next-Generation Oncology Solution Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Next-Generation Oncology Solution Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Next-Generation Oncology Solution Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Next-Generation Oncology Solution Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Next-Generation Oncology Solution Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Next-Generation Oncology Solution Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Next-Generation Oncology Solution Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Next-Generation Oncology Solution Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Next-Generation Oncology Solution Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Next-Generation Oncology Solution Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Next-Generation Oncology Solution Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Next-Generation Oncology Solution Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Next-Generation Oncology Solution Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 64. Illumina Company Details
Table 65. Illumina Business Overview
Table 66. Illumina Next-Generation Oncology Solution Product
Table 67. Illumina Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 68. Illumina Recent Developments
Table 69. PerkinElmer Company Details
Table 70. PerkinElmer Business Overview
Table 71. PerkinElmer Next-Generation Oncology Solution Product
Table 72. PerkinElmer Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 73. PerkinElmer Recent Developments
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Next-Generation Oncology Solution Product
Table 77. Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 78. Thermo Fisher Scientific Recent Developments
Table 79. Roche Holding Company Details
Table 80. Roche Holding Business Overview
Table 81. Roche Holding Next-Generation Oncology Solution Product
Table 82. Roche Holding Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 83. Roche Holding Recent Developments
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Next-Generation Oncology Solution Product
Table 87. Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 88. Agilent Technologies Recent Developments
Table 89. Paige Company Details
Table 90. Paige Business Overview
Table 91. Paige Next-Generation Oncology Solution Product
Table 92. Paige Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 93. Paige Recent Developments
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Next-Generation Oncology Solution Product
Table 97. GE Healthcare Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 98. GE Healthcare Recent Developments
Table 99. Varian Company Details
Table 100. Varian Business Overview
Table 101. Varian Next-Generation Oncology Solution Product
Table 102. Varian Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 103. Varian Recent Developments
Table 104. Brainlab Company Details
Table 105. Brainlab Business Overview
Table 106. Brainlab Next-Generation Oncology Solution Product
Table 107. Brainlab Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 108. Brainlab Recent Developments
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen Next-Generation Oncology Solution Product
Table 112. Qiagen Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 113. Qiagen Recent Developments
Table 114. Hologic Company Details
Table 115. Hologic Business Overview
Table 116. Hologic Next-Generation Oncology Solution Product
Table 117. Hologic Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 118. Hologic Recent Developments
Table 119. Pacific Biosciences Company Details
Table 120. Pacific Biosciences Business Overview
Table 121. Pacific Biosciences Next-Generation Oncology Solution Product
Table 122. Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 123. Pacific Biosciences Recent Developments
Table 124. AstraZeneca Company Details
Table 125. AstraZeneca Business Overview
Table 126. AstraZeneca Next-Generation Oncology Solution Product
Table 127. AstraZeneca Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 128. AstraZeneca Recent Developments
Table 129. BGI Group Company Details
Table 130. BGI Group Business Overview
Table 131. BGI Group Next-Generation Oncology Solution Product
Table 132. BGI Group Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 133. BGI Group Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next-Generation Oncology Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Next-Generation Oncology Solution Market Share by Type: 2022 VS 2033
Figure 3. Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy) Features
Figure 4. Software Features
Figure 5. Others Features
Figure 6. Global Next-Generation Oncology Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Next-Generation Oncology Solution Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Imaging Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Next-Generation Oncology Solution Report Years Considered
Figure 12. Global Next-Generation Oncology Solution Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Next-Generation Oncology Solution Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Next-Generation Oncology Solution Market Share by Region: 2022 VS 2033
Figure 15. Global Next-Generation Oncology Solution Market Share by Players in 2022
Figure 16. Global Top Next-Generation Oncology Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Oncology Solution as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Next-Generation Oncology Solution Revenue in 2022
Figure 18. North America Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Next-Generation Oncology Solution Market Share by Type (2018-2033)
Figure 20. North America Next-Generation Oncology Solution Market Share by Application (2018-2033)
Figure 21. North America Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 22. United States Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Next-Generation Oncology Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Next-Generation Oncology Solution Market Share by Type (2018-2033)
Figure 26. Europe Next-Generation Oncology Solution Market Share by Application (2018-2033)
Figure 27. Europe Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 28. Germany Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Next-Generation Oncology Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Next-Generation Oncology Solution Market Share by Type (2018-2033)
Figure 36. China Next-Generation Oncology Solution Market Share by Application (2018-2033)
Figure 37. Asia Next-Generation Oncology Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Next-Generation Oncology Solution Market Share by Type (2018-2033)
Figure 39. Asia Next-Generation Oncology Solution Market Share by Application (2018-2033)
Figure 40. Asia Next-Generation Oncology Solution Market Share by Region (2018-2033)
Figure 41. Japan Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 51. Brazil Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Illumina Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 58. PerkinElmer Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 60. Roche Holding Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 61. Agilent Technologies Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 62. Paige Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 63. GE Healthcare Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 64. Varian Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 65. Brainlab Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 66. Qiagen Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 67. Hologic Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 68. Pacific Biosciences Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 69. AstraZeneca Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 70. BGI Group Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries